Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,412,284 | 1,315,300 | 1,117,279 | 1,127,824 | 1,001,599 |
| Cost of Goods | 196,510 | 164,606 | 165,002 | 160,560 | 170,462 |
| Gross Profit | 1,215,774 | 1,150,694 | 952,277 | 967,264 | 831,137 |
| Operating Expenses | 1,053,170 | 1,063,415 | 941,177 | 1,047,249 | 951,864 |
| Operating Income | 163,114 | 87,885 | 11,102 | -79,425 | -120,265 |
| Other Income | -15,950 | 11,664 | 9,798 | -5,926 | 21,961 |
| Pre-tax Income | 147,164 | 99,549 | 20,900 | -85,351 | -98,304 |
| Income Tax | 22,323 | 5,229 | 19,630 | 66,530 | 23,046 |
| Net Income Continuous | 124,841 | 94,320 | 1,270 | -151,881 | -121,350 |
| Net Income | $124,841 | $94,320 | $1,270 | $-151,881 | $-121,350 |
| EPS Basic Total Ops | 1.13 | 0.87 | 0.01 | -1.41 | -1.15 |
| EPS Basic Continuous Ops | 1.13 | 0.87 | 0.01 | -1.42 | -1.15 |
| EPS Diluted Total Ops | 1.09 | 0.84 | 0.01 | -1.41 | -1.15 |
| EPS Diluted Continuous Ops | 1.09 | 0.84 | 0.01 | -1.42 | -1.15 |
| EPS Diluted Before Non-Recurring Items | 1.09 | 0.84 | 1.22 | -1.43 | -1.15 |
| EBITDA(a) | $200,398 | $123,499 | $43,906 | $-29,179 | $-48,973 |